CE-mark for Baxter's mechanical heart valve:
This article was originally published in Clinica
Baxter has CE-marked its bileaflet mechanical heart valve. The Edwards MIRA valve features a unique sewing ring and is suitable for a wide variety of surgical techniques, including minimally-invasive procedures. The company plans to begin clinical trials of the device in the US in 1998, pending approval of an investigational device exemption application by the FDA. Baxter estimated that over 250,000 patients worldwide undergo surgery every year to repair or replace diseased or defective heart valves.
You may also be interested in...
Dispatches from a world turned upside down include FDA expressing confidence in Chinese manufacturers – to make their GDUFA payments; projections of drug shortages for ventilator patients; and the launch of new hydroxychloroquine studies.
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.